The potential of UK clinical databases in enhancing paediatric medication research
- 7 June 2005
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 59 (6) , 750-755
- https://doi.org/10.1111/j.1365-2125.2005.02450.x
Abstract
The research potential of many UK clinical databases is not being realized. A recent report published by the Royal College of Paediatrics & Child Health stated that there is a need to build research capacity and support in the area of paediatric pharmacology, with specific emphasis on the use of clinical databases. This article presents the databases available in the UK for medication research and gives some examples of paediatric studies conducted. The databases discussed include the Prescription Pricing Authority database, the General Practice Research Database, IMS Health databases (Medical Data Index, MIDAS Prescribing Insights, Disease-Analyser-Mediplus) and the Yellow Card Scheme. Other databases such as the Medicines Monitoring Unit (MEMO) and the Scottish Primary Care Computer System also have research potential in paediatric pharmacoepidemiology, but their population sizes are relatively small.Keywords
This publication has 11 references indexed in Scilit:
- A drug utilisation study of antidepressants in children and adolescents using the General Practice Research DatabaseArchives of Disease in Childhood, 2004
- Increased prescribing trends of paediatric psychotropic medicationsArchives of Disease in Childhood, 2004
- MMR vaccination and pervasive developmental disorders: a case-control studyThe Lancet, 2004
- Cross sectional survey of multicentre clinical databases in the United KingdomBMJ, 2004
- Potential benefits of the UK Cystic Fibrosis Database.2004
- Rise in Psychotropic Drug Prescribing in Children in the UKDrug Safety, 2003
- Surveillance for fatal suspected adverse drug reactions in the UKArchives of Disease in Childhood, 2002
- Burden of corticosteroids in children with asthma in primary care: retrospective observational studyBMJ, 2002
- The use of newly marketed drugs in children and adolescents prescribed in general practicePharmacoepidemiology and Drug Safety, 1999
- Prescription‐event monitoring—recent progress and future horizonsBritish Journal of Clinical Pharmacology, 1998